267 related articles for article (PubMed ID: 31350988)
1. Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer.
Elsharkawi F; Elsabah M; Shabayek M; Khaled H
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2219-2224. PubMed ID: 31350988
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs in blood and urine as diagnostic and prognostic biomarkers for bladder cancer: an update in 2017.
Tölle A; Blobel CC; Jung K
Biomark Med; 2018 Jun; 12(6):667-676. PubMed ID: 29896971
[TBL] [Abstract][Full Text] [Related]
3. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.
Ismail MF; El Boghdady NA; Shabayek MI; Awida HA; Abozeed H
Tumour Biol; 2016 Apr; 37(4):4621-31. PubMed ID: 26508026
[TBL] [Abstract][Full Text] [Related]
5. The determination of serum and urinary endocan concentrations in patients with bladder cancer.
Laloglu E; Aksoy H; Aksoy Y; Ozkaya F; Akcay F
Ann Clin Biochem; 2016 Nov; 53(6):647-653. PubMed ID: 26748103
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment.
Georgantzoglou N; Pergaris A; Masaoutis C; Theocharis S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803085
[TBL] [Abstract][Full Text] [Related]
7. Serum periplakin as a potential biomarker for urothelial carcinoma of the urinary bladder.
Matsumoto K; Ikeda M; Matsumoto T; Nagashio R; Nishimori T; Tomonaga T; Nomura F; Sato Y; Kitasato H; Iwamura M
Asian Pac J Cancer Prev; 2014; 15(22):9927-31. PubMed ID: 25520130
[TBL] [Abstract][Full Text] [Related]
8. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
[TBL] [Abstract][Full Text] [Related]
9. Serum and urinary endocan levels for bladder cancer diagnosis.
Hu ZD
Ann Clin Biochem; 2016 Nov; 53(6):717. PubMed ID: 27141014
[No Abstract] [Full Text] [Related]
10. Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer.
Mohammed MA; Seleim MF; Abdalla MS; Sharada HM; Abdel Wahab AH
BMC Urol; 2013 May; 13():25. PubMed ID: 23672427
[TBL] [Abstract][Full Text] [Related]
11. Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.
Oeyen E; Hoekx L; De Wachter S; Baldewijns M; Ameye F; Mertens I
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769831
[TBL] [Abstract][Full Text] [Related]
12. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
Wang J; Yang K; Yuan W; Gao Z
Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP
Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests.
Goodison S; Rosser CJ; Urquidi V
Mol Diagn Ther; 2013 Apr; 17(2):71-84. PubMed ID: 23479428
[TBL] [Abstract][Full Text] [Related]
15. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
Kausch I; Böhle A
Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
Guo XG; Long JJ
Tumour Biol; 2016 Oct; 37(10):14329-14330. PubMed ID: 27448817
[TBL] [Abstract][Full Text] [Related]
17. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
[TBL] [Abstract][Full Text] [Related]
18. Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
Mbeutcha A; Lucca I; Mathieu R; Lotan Y; Shariat SF
Urol Clin North Am; 2016 Feb; 43(1):47-62. PubMed ID: 26614028
[TBL] [Abstract][Full Text] [Related]
19. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancer.
Kelloniemi E; Rintala E; Finne P; Stenman UH;
Urology; 2003 Aug; 62(2):249-53. PubMed ID: 12893328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
